
Sarah Green
@viridanspharmd
ID/ASP Pharmacist 🤓 at Emory University Hospital | #UNCPharmD | Opinions my own
ID: 792128027329073152
28-10-2016 22:16:53
129 Tweet
191 Followers
207 Following





Although long-acting CAB/RPV is FDA-approved only for PWH w/ viral suppression, this remarkable case series (new in Clinical Infectious Diseases) shows it can work also in those with viremia -- where it could be a life-saving intervention. Clinical trials urgently needed. doi.org/10.1093/cid/ci…


It wasn't easy writing this. Thanks to Preeti Malani for allowing me to share it. Rosa ja.ma/3bYJT4I via JAMA part of JAMA Network


Atlanta ID pharmacists carving out time to make spooky ID pumpkins #IDTwitter #TwitteRx Sarah Green Trinh Vu Tiffany Goolsby, PharmD, BCIDP Summer Sizemore




🆕️⚡️⚡️ Open Forum Infectious Diseases Chris Bland P. Brandon Bookstaver Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in Non-Hospital Care Settings in 2021 #IDTwitter #MedEd #twitterx academic.oup.com/ofid/advance-a…

Antibiotic stewards are answering the call for ASP efforts beyond the hospital setting! We expanded the SE Research Group Baker's Dozen to meet the demand for high-quality, non-hospital ASP interventions 🎉 academic.oup.com/ofid/advance-a…

Thank you to our 🌟 ID/ASP author team for pioneering the first non-hospital Baker's Dozen Ashley Marx @Albrechtazole Jillian Hayes @KaBar_33 Matt Brown Spencer Durham @GabrielleFurgiu Lacie McKamey Summer Sizemore Michelle Turner Hana Rac Winders P. Brandon Bookstaver Chris Bland

🆕️⚡️⚡️ Open Forum Infectious Diseases by 🌟s Chris Bland P. Brandon Bookstaver Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications for Hospitalized Patients in 2021 #IDTwitter academic.oup.com/ofid/advance-a…

Excited to publish our SE Research Group Baker’s Dozen ASP intervention articles for hospitalized patients. Fantastic job leading by Ashley Marx to complete our 5th straight year publishing with Open Forum Infectious Diseases. Congrats to all the authors whose great work is highlighted.


***STUDY OPPORTUNITY*** Dalbavancin use in suppression Retrospective study investigating dosing strategies, safety & effectiveness. If you have >/= 1 case of dalba use for suppression, please contact us @Bbookstaver_USC or Michael Shaw to discuss. #IDTwitter #TwitteRx (1/2)

Learn more about ways to increase access to opioid use disorder treatment in the HIV care setting! ACCP HIV PRN Sarah Green tandfonline.com/doi/full/10.10…

So exciting to have a front row seat to such amazing presentations! You guys absolutely nailed it! SUDAmonas Nick Mercuro John Veillette Chris Bland